ea0041ep550 | Diabetes therapy | ECE2016
de Linares Lidia Urbon Lopez
, Soto Maria Cristina Crespo
, Terroba Concepcion
, Ventosa Marta
, Martin Tomas
, Calleja Maria del Mar
, Cuellar Luis Angel
Changes in HbA1c and weight after 1 year on dapaglifozina added to the previous treatment.SGLT2 inhibitors are becoming a common and useful drug to treat type 2 diabetes.The inhibition of the sodium-glucose co transporters (SLGT2) inhibits also the glucose reabsorption in the proximale tubule and increases the glucose excreted in the urine.Therefore hyperglycemia decreases and so does weight as happens with t...